Education
About Us
Working with TipRanks
Follow Us
Metsera, Inc. (MTSR)
NASDAQ:MTSR
Met233
Obesity And Overweight
Phase I/II
Recruiting
A Study of MET233 in Individuals With Obesity or Overweight
Jun 06, 2025
―
Met097
Obesity, Overweight Or Obesity
Phase II
Active Not Recruiting
A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight
May 06, 2025
―
Met233 And Met097, Met233
Obesity And Obesity-Related Medical Conditions
Phase I
Recruiting
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
Apr 03, 2025
―
Met097 Injection
Type 2 Diabetes Mellitus (T2dm), Obesity In Diabetes
Phase II
Recruiting
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM
Mar 13, 2025
―
(Part C) Met097
Obesity And Overweight
Phase I/II
Active Not Recruiting
This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity
Jan 14, 2025
―
Met097
Obesity, Overweight Or Obesity
Phase II
Active Not Recruiting
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight
Nov 27, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Metsera, Inc. (MTSR) have in its pipeline
MTSR is currently developing the following drugs: Met233, Met097, Met233 And Met097, Met233. These drug candidates are in various stages of clinical development as the company works toward FDA approval.